延长释放与子语言布普伦诺芬在怀孕期间通过12个月产后:一个随机临床试验
T John Winhusen1,2, Michelle R Lofwall3, Frankie Kropp1,2
1Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio.
JAMA internal medicine
|March 16, 2026
概括
延长释放布伦诺芬改善了阿片类药物使用障碍 (OUD) 的母亲在怀孕期间的非法阿片类药物戒断. 这种治疗也减少了严重的不良事件,与语言下布伦诺芬相比.
科学领域:
- 产科和妇科 产科和妇科
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
背景情况:
- 语言下布伦诺芬是治疗妊娠期间阿片类药物使用障碍 (OUD) 的标准.
- 延长释放 (ER) 布普伦诺芬配方可能比每日舌下服药具有优势.
- 这项研究评估了ER buprenorphine与OUD在怀孕期间的语言下 buprenorphine.
研究的目的:
- 为了评估ER布伦诺芬的有效性和安全性,与OUD的孕妇的舌下布伦诺芬相比.
- 通过产后12个月评估结果.
主要方法:
- 一项随机临床试验,涉及140名OUD和单胎怀孕的成年人.
- 参与者被随机分配到每周接受ER布伦诺芬或每天接受语言下布伦诺芬.
- 主要结局包括怀孕和产后非法阿片类药物戒断,次要结局是新生儿阿片类药物戒断综合征 (NOWS).
主要成果:
- 在怀孕期间观察到更高的非法阿片类药物戒断率,使用ER布诺芬 (82.5%) 与下语言 (72.6%) 相比.
- 在怀孕和产后期间,ER布诺芬组的严重不良事件显着较低.
- 婴儿的结果,包括需要NOWS治疗和治疗持续时间,在各组之间没有显著差异.
结论:
- 每周的ER布诺啡是治疗OUD在怀孕期间的可行和潜在的优越选择.
- 经期使用布普伦诺芬证明改善了母亲的禁欲和安全性.
- 进一步的研究可能会探索长期益处和最佳产后策略.
相关概念视频
01:26Oral Drug Delivery Systems: Continuous-Release Systems
162
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
162
01:21Intrauterine Drug Delivery Systems
101
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
101
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
131
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
131
01:18Drug Delivery: Enteral Route
2.3K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
2.3K
01:19Modified-Release Drug Delivery Systems: Overview
99
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
99